TY  - JOUR
AU  - Raj, Kavita
AU  - Eikema, Dirk-Jan
AU  - Sheth, Vipul
AU  - Koster, Linda
AU  - de Wreede, Liesbeth C
AU  - Blaise, Didier
AU  - Di Grazia, Carmela
AU  - Koc, Yener
AU  - Potter, Victoria
AU  - Chevallier, Patrice
AU  - Lopez-Corral, Lucia
AU  - Wu, Depei
AU  - Mielke, Stephan
AU  - Maertens, Johan
AU  - Meijer, Ellen
AU  - Huynh, Anne
AU  - Passweg, Jakob
AU  - Luft, Thomas
AU  - Pérez-Simón, Jose Antonio
AU  - Ciceri, Fabio
AU  - Piekarska, Agnieszka
AU  - Hayri Ozsan, G
AU  - Kröger, Nicolaus
AU  - Robin, Marie
AU  - Yakoub-Agha, Ibrahim
PY  - 2022
DO  - 10.1038/s41408-022-00729-y
UR  - http://hdl.handle.net/10668/19519
T2  - Blood cancer journal
AB  - Myelodysplastic syndromes (MDS) are the second common indication for an Allo-HCT. We compared the outcomes of 1414 matched sibling (MSD) with 415 haplo-identical donors (HD) transplanted with post-transplant cyclophosphamide (PTCy) as GVHD prophylaxis...
LA  - en
KW  - Adult
KW  - Cyclophosphamide
KW  - Graft vs Host Disease
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Middle Aged
KW  - Myelodysplastic Syndromes
KW  - Neoplasms
KW  - Recurrence
KW  - Retrospective Studies
KW  - Siblings
KW  - Transplantation Conditioning
KW  - Unrelated Donors
TI  - Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT.
TY  - research article
VL  - 12
ER  -